 CUPERTINO, Calif., Jan. 4, 2021 PRNewswire -- DURECT Corporation Nasdaq: DRRX today announced that the sale of the LACTEL product line to Evonik closed and the 15 million payment was received on December 31, 2020. About DURECT Corporation DURECT is a biopharmaceutical company... 